Schnieders Capital Management LLC Novartis Ag Transaction History

Schnieders Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$64.91 - $73.36 $190,251 - $215,018	-2,931 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$70.39 - $84.15 $7,039 - $8,415	100 Added 3.53%	2,931 $237,000
Q4 2017 Feb 08, 2018	SELL	$72.33 - $77.64 $75,946 - $81,522	-1,050 Reduced 27.05%	2,831 $238,000
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $287,737 - $299,884	3,881	3,881 $333,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Schnieders Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Schnieders Capital Management LLC with notifications on news.